Amgen (NASDAQ:AMGN – Free Report) had its target price hoisted by Morgan Stanley from $271.00 to $310.00 in a research note issued to investors on Friday, Benzinga reports. Morgan Stanley currently has an equal weight rating on the medical research company’s stock. Other research analysts also recently issued research reports about the stock. SVB Leerink […]
Related Keywords
Canada , Nancya Grygiel , Leerink Partnrs , Amgen Company Profile , Morgan Stanley , International Assets Investment Management , Securities Exchange Commission , Barclays , Norges Bank , Royal Bank , Amgen , Amgen Inc , Free Report , Moderate Buy , Stock Down , Get Free Report , Exchange Commission , Assets Investment Management , Amgen Daily , Nasdaq Amgn , Amgn , Medical , 03116210 , Boost Price Target ,
comparemela.com © 2020. All Rights Reserved.